RO 462153
Latest Information Update: 09 Nov 2006
Price :
$50 *
At a glance
- Originator Roche
- Class Benzodiazepines
- Mechanism of Action GABA A receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders
Most Recent Events
- 09 Nov 2006 Discontinued - Clinical-Phase-Unknown for Anxiety disorders in Switzerland (PO)
- 22 Mar 2001 New profile
- 22 Mar 2001 Investigation in Anxiety disorders in Switzerland (PO)